Early immunomodulatory program triggered by pro-tolerogenic Bifidobacterium pseudolongum drives cardiac transplant outcomes
S. J. Gavzy, A. Kensiski, V. Saxena, R. Lakhan, L. Hittle, L. Wu, J. Iyyathurai, H. Dhakal, Z. L. Lee, L. Li, Y. Lee, T. Zhang, H. W. Lwin, M. W. Shirkey, C. Paluskievicz, , J. S. Bromberg
This study identifies Bifidobacterium pseudolongum as inducing an early anti-inflammatory response that influences cardiac transplant outcomes.
bioRxiv · Oct 13, 2022 · PreprintImmunology